Potransplantacyjne choroby limfoproliferacyjne — rekomendacje diagnostyki i leczenia Polskiej Grupy Badawczej Chłoniaków w 2025 roku
Post-transplant lymphoproliferative disorders (PTLD) are a category of iatrogenic lymphoproliferative syndromes associated with immunodeficiencies. PTLD is defined as any lymphoproliferation (except lymphoproliferation from small B lymphocytes) occurring after organ transplantation or allogeneic hematopoietic stem cell transplantation, regardless of the time elapsed since transplantation. The diagnosis of PTLD is based on histopathological examination of the lymph node or suspicious lesion. The main treatment goal is eradication of PTLD, with a concomitant maintenance of graft function. This article presents the latest diagnosis and treatment recommendations of the Polish Lymphoma Research Group.
Authors
- Ewa Lech‐Marańda (ORCID: https://orcid.org/0000-0001-9592-0851)
- Anna Czyż (ORCID: https://orcid.org/0000-0001-6641-0182)
- L. Gil (ORCID: https://orcid.org/0000-0002-0797-1841)
- Sebastian Giebel (ORCID: https://orcid.org/0000-0002-4827-4401)
- Bartosz Puła (ORCID: https://orcid.org/0000-0003-0116-5002)
- Jan Zaucha (ORCID: https://orcid.org/0000-0003-3289-4590)
- Joanna Ewa Drozd-Sokolowska (ORCID: https://orcid.org/0000-0002-4562-6264)
- Jan Styczyński (ORCID: https://orcid.org/0000-0002-3158-119X)
- Tomasz Wróbel (ORCID: https://orcid.org/0000-0001-9194-9753)
Institutions
- Poznan University of Medical Sciences (PL)
- Medical University of Warsaw (PL)
- Nicolaus Copernicus University (PL)
- Wroclaw Medical University (PL)
- Institute for Transfusion Medicine (US)
- Instytut Hematologii i Transfuzjologi (PL)
- Copernicus Memorial Hospital (PL)
- The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
- Gdańsk Medical University (PL)
Publication Details
- Journal
- Hematologia — Edukacja
- Published
- 2025-03-27
- DOI
- https://doi.org/10.5603/ahp.103957
- Citations
- 1
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.05